baber/WOPTO huggingface dataset:
Patent AU-700051-B2 (AU)
Title: A method of controlling a direct-current drive
Inventor: GRINEWITSCHUS VIKTOR
IPC: H02H7/085
Filed: 1996-12-27
Granted: 1998-12-17
Abstract: PCT No. PCT/EP96/05850 Sec. 371 Date Jul. 13, 1998 Sec. 102(e) Date Jul. 13, 1998 PCT Filed Dec. 27, 1996 PCT Pub. No. WO97/26694 PCT Pub. Date Jul. 24, 1997In a method of controlling a direct-current drive, in particular a direct-current door drive, two state variables of the direct-current drive are determined and, on the basis of these state variables, a load or resistance moment applied to the direct-current drive is determined and compared with a predetermined load or resistance moment. Subsequently, it is established that an abnormal situation exists when the load or resistance moment determined exceeds the predetermined load or resistance moment.
Patent AU-783343-B2 (AU)
Title: Device for anchoring one end of a stay to a base
Inventor: BOURNAND YVES
IPC: E04C5/12
Filed: 2002-01-25
Granted: 2005-10-20
Abstract: This invention relates to a device (1) for anchoring one end (2A) of a stay (2) to a base (3), this end (2A) of the stay (2) comprising at least two strands (2B) which diverge from its longitudinal axis (2C) in such a way as to come to be anchored in the device (1), these strands (2B) each being made up of a core wire (2D) and a protective sheathing (2E), the device itself being intended to be positioned and immobilised in translation in a bore (3A) provided in the base (3),     this device (1) comprising a first rigid unit (4), which :   is delimited transversally by a cylindrical face (4A) and longitudinally by two opposite faces (4B, 4C) substantially orthogonal to the longitudinal axis (4D) of said first unit (4), is traversed by perforations (4E) which, made substantially parallel to its longitudinal axis (4D), are each intended for passage of one end (2F), devoid of sheathing (2E), of a strand (2B) of the stay (2), and each including a bearing surface (4F) intended to co-operate with an immobilisation piece (4G) of such an end (2A) devoid of sheathing (2E), bears at least one tubular element (5C) to cover, over a certain distance (L1) measured from one (4C) of its opposite faces (4B, 4C), the bundle of strands (2B) in a water-tight way at least in its part where the strands (2B) are devoid of sheathing (2E).   <IMAGE>
Patent AU-602569-B2 (AU)
Title: Oxygenate additives for alcohol based fuels to reduce deposits in carburators and injection devices for motors
Inventor: HAMMER HARTMUT DR
IPC: C10L1/26
Filed: 1988-04-11
Granted: 1990-10-18
Abstract: In engines in which alcohol fuels are used together with lubricants, these contain a small quantity of one or more compounds based on polyol ethers and are suitable for engines run with hydrocarbon fuels.
Patent AU-765914-B2 (AU)
Title: An agile network protocol for secure communications with assured system availability
Inventor: MUNGER EDMUND C
IPC: H04L45/24
Filed: 1999-10-29
Granted: 2003-10-02
Abstract: A plurality of computer nodes communicates using seemingly random IP source and destination addresses and (optionally) a seemingly random discriminator field. Data packets matching criteria defined by a moving window of valid addresses are accepted for further processing, while those that do not meet the criteria are rejected. In addition to "hopping" of IP addresses and discriminator fields, hardware addresses such as Media Access Control addresses can be hopped. The hopped addresses are generated by random number generators having non-repeating sequence lengths that are easily determined a-priori, which can quickly jump ahead in sequence by an arbitrary number of random steps and which have the property that future random numbers are difficult to guess without knowing the random number generator's parameters. Synchronisation techniques can be used to re-establish synchronization between sending and receiving nodes. These techniques include a self-synchronization technique in which a sync field is transmitted as part of each packet, and a "checkpoint" scheme by which transmitting and receiving nodes can advance to a known point in their hopping schemes. A fast-packet reject technique based on the use of presence vectors is also described.
Patent AU-729025-B2 (AU)
Title: A multiple-layer article having a plastic member with a surface application material effectively bonded thereto and a method of making same
Inventor: HETTINGA SIEBOLT
IPC: B29C45/14
Filed: 1997-03-21
Granted: 2001-01-25
Abstract: A multiple-layer article (10) having a surface application material (20) effectively bonded to an injection molded plastic member (12) is provided along with a method for making same. At least a portion of an intermediary substratum (14) is located inside a mold cavity (28) during injection of a plastic injection material where the plastic injection material (30) contacts and becomes partially absorbed into a first side (16) of the intermediary substratum (14). The plastic member and the intermediary substratum are then removed from the mold cavity, and the surface application material (20) is applied to a second side (18) of the intermediary substratum where the surface application material becomes partially absorbed into the second side of the intermediary substratum.
Patent AU-723900-B2 (AU)
Title: Isolation and amplification of nucleic acid materials
Inventor: GOUDSMIT JAAP
IPC: C12Q1/6806
Filed: 1997-02-14
Granted: 2000-09-07
Abstract: The invention relates to methods for easily separating single stranded nucleic acid material from double stranded nucleic acid material in a sample containing both. By the right choice of at lease one chaotropic agent, preferably a guanidine salt, at a selected concentration and other suitable conditions such a chelating agents, pH and the like, it is possible to bind double stranded material to a solid phase such as silica particles, whereas single stranded material will not bind under those circumstances. By separating the silica particles from the sample the double stranded nucleic acid material is removed. It can easily be eluted from the silica particles. In a second step the single stranded material may be bound to a solid phase by selecting a different set of conditions. The particles can again be separated from the sample and the single stranded material may now be eluted. For very efficent separations, the process may be repeated. Following the separation of the two kinds of nucleic acid, either kind may be amplified. Methods of amplification are provided which do not need sequence data of the material to be amplified. In these methods a primer will be provided with an amplification motif and a random hybridization motif.
Patent AU-686329-B2 (AU)
Title: Endmill adapter with torque reducing locknut and collet interface
Inventor: LEWIS DAVID L
IPC: B23C5/26
Filed: 1995-01-17
Granted: 1998-02-05
Abstract: A toolholder 1 of the type including a collet 5 integrally formed with a shank 3 is provided with an interface between a locknut 7 and collet 13 which substantially reduces the torque required to turn the locknut 7 into a position which radially collapses the collet segments 17. In this interface, one of either the inner locknut surface 23 or the outer surfaces of the collet segments 17 includes an engaging portion 56 for wedgingly flexing the collet segments 17 inwardly when the locknut is turned, and a non-engaging portion 58 disposed between the engaging portion 56 and the shank mounted ends of the collet segments 17. The non-engaging portion 58 reduces the torque required to turn the locknut 7 by reducing the binding forces that would otherwise occur between the ends of the collet segments 17 and the inner locknut surface 23. To further reduce torque, the collet portion interconnecting the collet segments 17 with the shank 3 of the toolholder is rendered thinner by the provision of circumferential grooves 72, 76 that make the collet segments 17 more flexible. Sealing rings 66, 74, 81 are seated in grooves 68, 72, 76 present in the interior defined by the collet segments 17 in order to prevent errant flows of coolant or debris from collecting between the collet segments 17 and the tool shank 9 gripped thereby.
Patent AU-553551-B2 (AU)
Title: Copy machine with stapel remover
Inventor: HOVENS JOHANNES FREDERIK JOSEF
IPC: B25C11/00
Filed: 1983-08-01
Granted: 1986-07-17
Abstract: Copying machine the top of which has a cavity (5) in which a flat strip (11) is provided with which a staple can be removed from a bundle or originals to be copied, the removed staple being received in the cavity (5). 
<??>A free end (13) of the strip (11) tapers to a point and is bent upwards in order to project somewhat above the copying machine. 
<??>By manually moving the bundle, with the bent-over legs of the staple facing upwardly, over the strip (11), the pointed end (13) of the strip (11) can engage the staple and upon further movement of the bundle the staple is pulled out of the bundle.
Patent AU-684140-B2 (AU)
Title: Process for the gas phase polymerization of alpha-olefins
Inventor: GOVONI GABRIELE
IPC: C08F10/00
Filed: 1995-02-15
Granted: 1997-12-04
Abstract: PCT No. PCT/EP95/00544 Sec. 371 Date Dec. 8, 1995 Sec. 102(e) Date Dec. 8, 1995 PCT Filed Feb. 15, 1995 PCT Pub. No. WO95/22565 PCT Pub. Date Aug. 24, 1995A process for polymerizing olefins using a fluidized bed, in which the monomer entry point is located at a point above the bed height. A pre-polymerization step can be conducted using a Z/N catalyst along with an alkane diluent, and resultant liquid phase is introduced into the fluidized bed above the bed height. The process may use several reactors in series arrangement.
Patent AU-744757-B2 (AU)
Title: Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity
Inventor: KLEIN ELLIOTT S
IPC: A61K31/165
Filed: 1998-12-21
Granted: 2002-03-07
Abstract: 2,2-Dialkyl-4-aryl-substituted benzopyran and benzothiopyran derivatives of the formula where the symbols have the meaning described in the specification, have retinoid negative hormone and/or antagonist-like biological activities. The invented RAR antagonists can be administered to mammals, including humans, for the purpose of preventing or diminishing action of RAR agonists on the bound receptor sites. Specifically, the RAR agonists are administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors. The retinoid negative hormones can be used to potentiate the activities of other retinoids and nuclear receptor agonists.
Patent AU-691280-B2 (AU)
Title: Bell system and/or multiple door intercom system
Inventor: TRAUTVETTER MANFRED
IPC: H04M11/02
Filed: 1995-04-28
Granted: 1998-05-14
Abstract: It is the aim of the invention to provide a door intercom and bell system making it possible to provide additional functions besides the bell and largely avoid additional wiring. This aim is achieved in that the keypad and the call system in the dwelling are connected via a bus system to a microcontroller and electronically controlled indicators are fitted as identification plates. The invention relates to a door intercom and bell system with a keypad having at least one identification plate.
Patent AU-616693-B2 (AU)
Title: Instant oral-release capsule containing nifedipine
Inventor: MILLER RONALD BROWN
IPC: A61K31/44
Filed: 1988-11-10
Granted: 1991-11-07
Abstract: The invention concerns an instant oral-release capsule containing an aqueous or aqueous alcoholic solution of nifedipine, containing a polyalkylene glycol and a polyoxyethylene ester component, the amount of the ester component in the solution being sufficient to prevent precipitation of nifedipine in the mouth of a patient after release of the solution from the capsule. Preferably, the ester component is an ethoxylated hydrogenated castor oil Cremophor RH40. The solution may further contain a second glycol component, especially glycerol.
Patent AU-597518-B2 (AU)
Title: Process for the production of microcapsules, the microcapsules obtainable according to it and the use thereof
Inventor: PIETSCH GUNTER
IPC: B01J13/02
Filed: 1988-12-16
Granted: 1990-05-31
Abstract: 1. Process for the production of microcapsules by microencapsulating hydrophobic oils, particularly with substances contained therein, in which the hydrophobic oil is mixed, accompanied by vigorous stirring, into an aqueous medium containing a dispersion-stabilizing compound, the oil-in-water dispersion obtained is acid-adjusted and aminoplastic capsules are formed in the conventional manner, characterised in that the aqueous medium contains a water-soluble, anionic, sulphonated melamine-formaldehyde precondensate as well as such a water-soluble non-filmforming cationic compound that the water-soluble non-filmforming compound interacts with the water-soluble, anionic, sulphonated melamine-formaldehyde precondensate to form a dispersion-stabilizing compound.
Patent AU-686400-B2 (AU)
Title: Serotonin 5-HT-1A and dopamin D-2 receptor ligands
Inventor: PERREGAARD JENS KRISTIAN
IPC: A61P9/10
Filed: 1995-06-08
Granted: 1998-02-05
Abstract: The present invention relates to a series of 4-phenylpiperazines of formula (I)  wherein A is alkylene, alkenylene, alkynylene, and C3-7 cycloalkylene; R1 is a C3-10 alkyl, alkenyl, or alkynyl group, cycloalk(en)yl, cycloalk(en)yl-alk(en/yn)yl, trifluoromethylsulfonyl, or alkylsulfonyl, R2-R5 are optional substituents; R9 and R10 are hydrogen, alkyl or together form an ethylene or propylene bridge, W is O or S; V is O, S, CR6R7, or NR8 wherein R6, R7, and R8 are hydrogen or alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, optionally substituted arylalkyl or aryl, or R6 and R7 constitute a 3-7 membered spiro ring; Z is-(CH2)m-; m being 2 or 3 or Z is -CH=CH-; which show effects on central serotonin 5-HT1A and dopamine D2 receptors. Thus the novel compounds are useful in the treatment of certain psychic and neurologic disorders, in particular psychosis.
Patent AU-658242-B2 (AU)
Title: Piperazine derivatives as 5-HT1A antagonists
Inventor: CLIFFE IAN ANTHONY
IPC: C07D311/22
Filed: 1992-12-01
Granted: 1995-04-06
Abstract: This invention concerns compounds of formula (I)  in optionally substituted by lower alkyl; Z is a bicyclic oxygen-containing aryl radical (e.g. 2,3-dihydro-1,4-benzodioxin-5-yl); R is hydrogen or lower alkyl; R1 is aryl or aryl(lower)alkyl; R2 is hydrogen or lower alkyl; and R3 is hydrogen, an alkyl group of 1 to 10 carbon atoms, cycloalkyl of 3 to 12 carbon atoms; cycloalkyl(lower)alkyl, aryl or aryl(lower)alkyl or R2 and R3 together with the nitrogen atom to which they are both attached represent a saturated heterocyclic ring which may contain a further hetero atom, and the pharmaceutically acceptable acid addition salts thereof. The compounds are 5-HT1A-antagonists which may be used, for example, in treating anxiety.
Patent AU-658040-B2 (AU)
Title: Novel megakaryocyte amplifier
Inventor: YAMAGUCHI NOZOMI
IPC: C12N15/12
Filed: 1992-12-24
Granted: 1995-03-30
Abstract: A novel megakaryocyte amplifier (Meg-POT) derived from man, which has a molecular weight of about 32,000 according to SDS-PAGE and contains in its molecule the following amino acid sequence: Gly Glu Thr Gly Gln Glu Ala Ala Pro Leu Asp Gly Val Leu. The Meg-POT is promising as a remedy for diseases caused by thrombocytopenia or platellet hypofunction. <IMAGE>
Patent AU-608147-B2 (AU)
Title: Reflector/refractor
Inventor: BARNES JOSH T
IPC: F21V5/02
Filed: 1989-04-07
Granted: 1991-03-21
Abstract: A reflector/refractor device (10) is provided for use with a variety of lighting fixtures and light sources. The reflector/refractor device (10) includes a body (16) having a predetermined profile and defining a cavity (22) with the body having an inside surface and an outside surface. An illuminating source (12) for emitting light is disposed within the cavity substantially along a central vertical axis (14) of the body. The body (16) includes a series of sectional zones for reflecting and refracting light. The exterior surface of the device includesd a plurality of substantially vertical prisms (P1-P7) consisting of reflective elements, refractive elements and elements (P1) that may be either reflective or refractive depending on light center location (LC). These reflective or refractive elements act in combination to selectively vary light distribution characteristics of vertical and lateral angles, and intensities, by vertical displacement of the illuminating lamp source.
Patent AU-707241-B2 (AU)
Title: Derivatives of beta-aminopropionic acid with a fungicidal activity
Inventor: CAMAGGI GIOVANNI
IPC: A01N43/40
Filed: 1995-10-10
Granted: 1999-07-08
Abstract: The present application relates to the use of compounds of formula (IX): <CHEM> wherein R1, R2, R3, Rc Ar and Q have the meanings given in the description, as fungicides.
Patent AU-658269-B2 (AU)
Title: RF power amplifier with linearization
Inventor: WRAY ANTONY JOHN
IPC: H03F1/32
Filed: 1993-02-25
Granted: 1995-04-06
Abstract: A radio transmitter circuit comprises a power amplifier (12) a lineariser circuit (10) for maintaining linearity in the power amplifier (12) and a feedback circuit (13) for feeding back a signal from an output of the power amplifier (12) to the linearising means for maintaining linearity, said power amplifier (12), lineariser circuit and feedback circuit forming a loop having adjustable loop linearisation parameters (for example phase and gain). A look-up table (19) is provided for storing predetermined loop linearisation parameters and a linear controller (18), coupled to the look-up table and the loop. The linear controller selects a loop linearisation parameter in response to a transmit control signal according to an operating condition input, such as battery level, frequency or temperature, at the time of receipt of the transmit control signal. Figure 2 shows an arrangement for detecting adjacent channel interference. <IMAGE>
Patent AU-668710-B2 (AU)
Title: Argatroban preparations for ophthalmic use
Inventor: MANO TOMIYA
IPC: A61K31/47
Filed: 1993-03-17
Granted: 1996-05-16
Abstract: The use of argatroban in the preparation of a medicament for preventing fibrin formation in the anterior chamber of mammals is provided. A medicament prepared by using argatroban may be in the form of an irrigating solution, an eye drop and a drip infusion in order to prevent fibrin formation in the anterior chamber.
Patent AU-659722-B2 (AU)
Title: Thermoplastic blends containing graft copolymers of polyacrylates as impact modifiers
Inventor: DENICOLA ANTHONY J JR
IPC: C08L21/00
Filed: 1993-03-30
Granted: 1995-05-25
Abstract: Disclosed are blends comprising a propylene polymer material grafted with a polymerizable monomer(s) of a polymer(s) having a Tg greater than 80 DEG C, a propylene polymer material grafted with a polymerizable monomer(s) of a polymer(s) having a Tg less than 20 DEG C, and optionally at least one other rubber modifier.
Patent AU-663930-B2 (AU)
Title: Method of analysing astigmatism and apparatus for performing corneal surgery
Inventor: ALPINS NOEL AMI
IPC: A61B3/107
Filed: 1993-03-04
Granted: 1995-10-26
Abstract: PCT No. PCT/AU93/00090 Sec. 371 Date Sep. 30, 1994 Sec. 102(e) Date Sep. 30, 1994 PCT Filed Mar. 4, 1993 PCT Pub. No. WO94/03133 PCT Pub. Date Feb. 17, 1994.A method of analyzing astigmatism is disclosed which enables surgeons to ascertain what surgery may be required subsequent to initial surgery to achieve the preoperative aim of the initial surgery. The method includes determining a preoperative astigmatism, defining an aimed astigmatism and determining an achieved astigmatism following initial surgery. The astigmatism values are initially determined in a zero to 180 degree range and are doubled to convert them to a 360 degree range. An aimed induced astigmatism vector, a surgically induced astigmatism vector and a difference vector are calculated. Magnitudes and angles of the vectors can be calculated to provide astigmatism magnitude values and angle values for modifying parameters of future surgery for improved performance of future surgery and for statistical analysis. The method also provides a rationale for determining a treatment parameter when spectacle and corneal astigmatism do not coincide.
Patent AU-768761-B2 (AU)
Title: Chimeric receptors
Inventor: LAWSON ALASTAIR DAVID GRIFFITH
IPC: C07K14/73
Filed: 1999-05-06
Granted: 2004-01-08
Abstract: DNA is described which codes for chimeric receptors which contain two or more independent polypeptide chains each of which contains an extra cellular ligand association domain attached to a signalling domain through a transmembrane and optionally one or more spacer domains. Each polypeptide chain can be expressed in an effector cell and will remain largely unassociated with the other(s) in the absence of ligand. The presence of ligand induces a stable interaction between the ligand association domains of each chain and facilitates interaction between the intracellular domains leading to a signalling event and activation of the cell. The activated cell may be of use in medicine for example in the treatment of diseases such as cancer.
Patent AU-677182-B2 (AU)
Title: Elastic net-like substrate having a layer of fibers pre-bonded thereto for use in an absorbent article
Inventor: COLES PETER
IPC: A61F5/44
Filed: 1993-03-11
Granted: 1997-04-17
Abstract: In an absorbent article, such as a diaper or incontinence briefs, an elastic member (60) comprising a net-like elastic substrate (62) to which fibers (64, 66) are pre-bonded provides for a breathable elastic for use as a side- a waist- or leg elastic. The fibers that are bonded to the net-like substrate, for instance by hydro-entangling, ensure a soft and comfortable contact with the wearer's skin. In the side panels of the absorbent article, the elastic members have a large freedom of stretch without buckling taking place, thus reducing chances of leakage. When the elastic member is located between the topsheet and the backsheet, a strong connection of topsheet to backsheet is established using a relatively small amount of adhesive.
Patent AU-691355-B2 (AU)
Title: Coating agents based on a sterically stablized, non-aqueous dispersion, process for their preparation and their use for coating packaging
Inventor: VOGDANIS LAZAROS
IPC: C09D183/00
Filed: 1995-10-21
Granted: 1998-05-14
Abstract: The invention concerns coating agents based on a sterically stabilized, non-aqueous dispersion which can be prepared by reacting, in an organic solvent in the presence of a dispersion stabilizer, at least one epoxy resin (A) having on average at least 2 epoxy groups per molecule, with at least one diol (B) of the formula HOROH (I), in which R is a group of the formula -Ph-D-Ph- (II), wherein -Ph- is a phenylene group and D is a methylene or propylene group, and optionally with a further component (C), which comprises groups which are reactive to epoxy or hydroxyl groups. The invention is characterized in that: i) the non-aqueous dispersion is prepared in that: 1) in a first step the epoxy resin component (A) is reacted with at least one diol (B) and optionally the component (C) to form a reaction product which contains as end groups phenolic hydroxyl groups and has a phenoxy equivalent weight of at least 246; and 2) subsequently, in step (2), 50 to 100 % of the phenolic hydroxyl groups present in the reaction product obtained in step (1) are reacted with another epoxy resin component (A) and/or component (C); and ii) the coating agent contains at least one phenolic resin.